P435-1739 Screening compound: 4-(2-{1-[5-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,2-oxazole-3-carbonyl]piperidin-4-yl}-5-methyl-1,3-oxazole-4-carbonyl)morpholine

P435-1739 Screening compound: 4-(2-{1-[5-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,2-oxazole-3-carbonyl]piperidin-4-yl}-5-methyl-1,3-oxazole-4-carbonyl)morpholine
P435-1739 Screening compound: 4-(2-{1-[5-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,2-oxazole-3-carbonyl]piperidin-4-yl}-5-methyl-1,3-oxazole-4-carbonyl)morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound P435-1739
4-(2-{1-[5-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,2-oxazole-3-carbonyl]piperidin-4-yl}-5-methyl-1,3-oxazole-4-carbonyl)morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P435-1739

Molecular Formula

C25H32N6O5 (C25 H32 N6 O5)

Compound Name

4-(2-{1-[5-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,2-oxazole-3-carbonyl]piperidin-4-yl}-5-methyl-1,3-oxazole-4-carbonyl)morpholine

IUPAC name

4-(2-{1-[5-(1-ethyl-35-dimethyl-1H-pyrazol-4-yl)-12-oxazole-3-carbonyl]piperidin-4-yl}-5-methyl-13-oxazole-4-carbonyl)morpholine

SMILES

CCn1nc(C)c(-c2cc(C(N(CC3)CCC3c3nc(C(N4CCOCC4)=O)c(C)o3)=O)no2)c1C

InChI

InChI=1S/C25H32N6O5/c1-5-31-16(3)21(15(2)27-31)20-14-19(28-36-20)24(32)29-8-6-18(7-9-29)23-26-22(17(4)35-23)25(33)30-10-12-34-13-11-30/h14,18H,5-13H2,1-4H3

InChI Key

GOJYWAODVFCQHC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31958407

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

496.57

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

1.318

Distribution Coefficient, logD

1.318

Water Solubility, LogSw

-1.52

Polar Surface Area

94.884

Acid Dissociation Constant (pKa)

26.24

Base Dissociation Constant (pKb)

3.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.00

P435-1739 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Agro:
  • Agro

References: we are preparing a list of scientific research reports with P435-1739 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P435-1739?
Check Price and Availability of P435-1739, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P435-1739 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P435-1739
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P435-1739
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P435-1739 available by request